List view / Grid view
8 January 2018 | By Dr Zara Kassam (Drug Target Review)
In a proof-of-principle case report, researchers announce that targeted fluorescence successfully identified pulmonary metastases in a patient with osteosarcoma...
2 November 2023 | By Drug Target Review
Percent necrosis calculated with machine learning model for patients with osteosarcoma provides an accurate prognosis for survival.
20 November 2023 | By Ellen Capon (Drug Target Review)
New imaging technology called fluorescence lifetime (FLT) imaging improves the accuracy of cancer surgery for multiple tumour types.
8 April 2019 | By Nic Losardo (Drug Target Review)
A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2 was found to be safe and showed clinical responses in paediatric and adult patients with advanced HER2-positive sarcoma...
20 June 2015 | By Horst Flotow (Singapore Screening Centre)
Cancer cells are addicted to glucose and glutamine, which enables them to generate the energy and macromolecule synthesis intermediates to support their growth...
23 September 2024 | By Drug Target Review
Following high-throughput drug screening of the tumour organoids, an effective FDA-approved treatment was identified.
6 December 2019 | By Hannah Balfour (Drug Target Review)
Researchers have reprogrammed CAR T cells to prevent them becoming exhausted after prolonged activity, presenting a possible new therapy for solid tumours.
